Symptoms of Acute Coronary Syndrome in Medical Regulation
SCAST+
1 other identifier
observational
208
1 country
1
Brief Summary
The main objective was to analyze the impact of the gender of the attending physician in the differences in the management of ST+ ACS between men and women. This study will be conducted in partnership with the interventional cardiology team of the CHR Metz-Thionville and SAMU (emergency call center) of Moselle, which has a detailed registry of coronary angiographies at the center. A retrospective observational study will be carried out over a "typical" period outside of covid at the CHR Metz Mercy (2021-2022) based on coronary angiographies performed in the context of ST+ ACS at the CHR of patients referred by the center 15. The patient's medical record will be analyzed, going back to his call to the 15 via tape listening. The number of subjects required being calculated at 104 men and 104 women, these patients will be selected from the database of our cardiologist colleagues and we will match one man to one woman by comparing the delays of several items (1st medical contact, time of 1st ECG, medicalization or not, delay of call to the cardiologist, delay of coronary angiography...) according to the sex of the regulator. The consequences of a difference in management will be also evaluated by analyzing in-hospital mortality, mortality at 30 days of management, and functional sequelae at discharge (grades of dyspnea, disturbance of myocardial contractility, LVEF at discharge). This study based on the differences in questioning according to the gender of the regulating physician would allow better identification of the factors that increase the delay in the management of ST+ ACS in women, and to find avenues of correction in order to limit the loss of opportunity for patients. The patients included who are still alive will receive a notification of non-objection by mail.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2023
CompletedFirst Submitted
Initial submission to the registry
May 22, 2023
CompletedFirst Posted
Study publicly available on registry
June 13, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2023
CompletedDecember 26, 2023
December 1, 2023
9 months
May 22, 2023
December 22, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Delay between the call to the emergency center and the first contact with a physician
Delay (minutes:seconds)
End of the call to the emergency center, less than 10 min
Secondary Outcomes (6)
Delay between the call to the emergency center and the first electrocardiogram
At hospital discharge, an average of 2 hours
Dispatch of a medical ambulance (Y/N)
End of the call to the emergency center, an average of 20 min
Delay between the call to the emergency center and the first coronary angiography
At hospital discharge, an average of 2 hours
In-hospital mortality
30 days after the call to emergency center
Day 30 mortality
30 days after the call to emergency center
- +1 more secondary outcomes
Interventions
Analysis of the differences in symptoms of a myocardial infarction between a man and a woman
Eligibility Criteria
The cohort includes patients admitted for coronary angiography at the Mercy hospital center in 2021-2022, having had a confirmed diagnosis of ACS ST+ and who made an initial call to the Moselle SAMU.
You may qualify if:
- patient with emergency coronary angiography for ST+ ACS
- having made a call to the Emergency Center for the same reason
You may not qualify if:
- non-real ST+ ACS
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHR Metz-Thionville/Hopital de Mercy
Metz, 57085, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Laure ABENSUR VUILLAUME, MD, PhD
CHR Metz Thionville Hopital de Mercy
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 22, 2023
First Posted
June 13, 2023
Study Start
January 1, 2023
Primary Completion
October 1, 2023
Study Completion
October 1, 2023
Last Updated
December 26, 2023
Record last verified: 2023-12
Data Sharing
- IPD Sharing
- Will not share